NATH BIO-GENES (I) LTD Fair Value
NATHBIOGEN · Fast Moving Consumer Goods · Current price ₹153.25
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹330 | 5% ROE fading to 12% over ~3 yrs, on ₹358 book |
| Relative P/E | ₹1,018 | EPS × 46.5 peer-median P/E |
| Graham floor | ₹420 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is NATH BIO-GENES (I) LTD undervalued?
DocStoX estimates the fair value of NATH BIO-GENES (I) LTD at ₹538 per share, versus the current market price of ₹153. That puts the stock about +250.8% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹330), Relative P/E (₹1,018), Graham floor (₹420). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹330 (bear) to ₹538 (base) to ₹1,018 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on NATH BIO-GENES (I) LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.